Author

Admin 422 posts 0 comments

Launching a new website to showcase its array of next-generation payment solutions…

Admin Apr 24, 2024

Leading provider of payment solutions, Opus Technologies, has launched a new website showcasing its wide array of…

FedNow Payments Are Added to Dragonfly Financial Technologies’ Digital…

Admin Apr 24, 2024

FinTech company Dragonfly Financial Technologies Corp., which specializes in digital banking and treasury…

Newer Posts

HUTCHMED to Announce 2026 Half-Year Financial Results

2026-06-30T08:30:00Z

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months...

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

2026-06-30T08:27:17Z

Tokyo, Japan and Cambridge and London, UK, 30 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has reached a fourth R&D milestone...

Zelluna ASA awarded NOK 16 million Research Council of Norway grant

2026-06-30T08:13:11Z

Oslo, 29 June 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announced that...

smartbax secures additional financing to advance lead antibiotic program to IND filing

2026-06-30T08:00:00Z

Munich, Germany, June 30, 2026 (GLOBE NEWSWIRE) -- smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, today announced the successful second closing of its Pre-Series A financing...

Transactions in connection with share buy-back program

2026-06-30T08:00:00Z

Company announcement no. 23 - 2630 June 2026

FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)

2026-06-30T05:00:00Z

Basel, 30 June 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental...

The National Proton Therapy Center of Portugal will be equipped with two IBA Proteus®ONE solutions

2026-06-30T05:00:00Z

Louvain-La-Neuve, Belgium, June 30, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the...

Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market

2026-06-30T05:00:00Z

ORION CORPORATION PRESS RELEASE 30 JUNE 2026 at 8.00 EEST

Addex Shareholders Approve All Resolutions at Annual General Meeting

2026-06-30T05:00:00Z

Ad Hoc Announcement Pursuant to Art. 53 LR

Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study

2026-06-30T05:00:00Z

Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study

Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock

2026-06-30T02:30:00Z

FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of...

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

2026-06-29T23:06:39Z

WESTLAKE VILLAGE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that the U.S. Food...

Twentyeight Health partners with Clue to expand access to affordable birth control nationwide

2026-06-29T21:54:19Z

Bridging the gap between daily cycle tracking and provider-led contraceptive care for personalized reproductive health

PetVivo Reports Financial and Operational Results for Fiscal 2026

2026-06-29T21:30:00Z

MINNEAPOLIS, MN, US, June 29, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo...

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

2026-06-29T21:17:00Z

Board-certified ophthalmologist and ASOPRS fellowship-trained surgeon Dr. Christopher I. Zoumalan, MD, FACS, explains how his trademarked Natural Looking Blepharoplasty® reflects the 2026 “less-is-more” movement in facial aesthetics.

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

2026-06-29T21:09:40Z

Acquisition Will Expand Patient Access, Strengthen Digital Healthcare Capabilities, and Create a Fully Vertically Integrated Medical Cannabis Framework for Tilray in Canada

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

2026-06-29T20:30:00Z

FDA sets updated PDUFA date of December 27, 2026

Publication relating to transparency notifications

2026-06-29T20:30:00Z

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

2026-06-29T20:15:00Z

Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delivery system

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

2026-06-29T20:14:00Z

Company Announcement

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

2026-06-29T20:09:41Z

New York, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Dragon Pharma Store announced the addition of KLOW 80mg to its online research product catalog, reflecting continued expansion of available laboratory...

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

2026-06-29T20:05:00Z

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

2026-06-29T20:05:00Z

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

2026-06-29T20:01:00Z

FORT LEE, NJ, June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of...

Lakefront Receives Transparency Notification from Madison Avenue Partners

2026-06-29T20:01:00Z

Mechelen, Belgium; June 29, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) received a transparency notification from Madison Avenue Partners.

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

2026-06-29T20:00:00Z

Châtillon, France, June 29, 2026

JellyFil Documents 2026 Supplement Facts Panel Composition, 8-Ingredient Proprietary Blend, and Manufacturing Disclosure for Its Gummy Dietary Supplement

2026-06-29T19:38:41Z

Once-daily men's gummy supplement featuring Maca, Ashwagandha, Tribulus, Arginine, Muira Puama, and Catuaba with 60-day money-back guarantee

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

2026-06-29T19:29:23Z

HOUSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Neutra Corp (OTC: NTRR), a company focused on health, wellness, and life sciences, today announced a series of operational milestones at its wholly...

Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville

2026-06-29T19:15:55Z

DUBLIN, June 29, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical...

Acorn Health Expands Autism Diagnostic Evaluations in Florida

2026-06-29T19:02:52Z

CORAL GABLES, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Acorn Health, a leading provider of Applied Behavior Analysis (ABA) therapy, has expanded autism diagnostic services in Florida. Comprehensive diagnostic evaluations...